- Home
- SPHL vs CDIO Comparison
SPHL vs CDIO Comparison
Compare SPHL & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- CDIO
- Stock Information
- Founded
- SPHL 2002
- CDIO 2017
- Country
- SPHL Singapore
- CDIO United States
- Employees
- SPHL N/A
- CDIO N/A
- Industry
- SPHL Homebuilding
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SPHL Consumer Discretionary
- CDIO Health Care
- Exchange
- SPHL Nasdaq
- CDIO Nasdaq
- Market Cap
- SPHL 6.0M
- CDIO 6.4M
- IPO Year
- SPHL 2024
- CDIO N/A
- Fundamental
- Price
- SPHL $0.43
- CDIO $3.81
- Analyst Decision
- SPHL
- CDIO
- Analyst Count
- SPHL 0
- CDIO 0
- Target Price
- SPHL N/A
- CDIO N/A
- AVG Volume (30 Days)
- SPHL 49.1K
- CDIO 34.0K
- Earning Date
- SPHL 01-01-0001
- CDIO 08-14-2025
- Dividend Yield
- SPHL N/A
- CDIO N/A
- EPS Growth
- SPHL N/A
- CDIO N/A
- EPS
- SPHL N/A
- CDIO N/A
- Revenue
- SPHL $6,456,601.00
- CDIO $19,507.00
- Revenue This Year
- SPHL N/A
- CDIO $1,434.82
- Revenue Next Year
- SPHL N/A
- CDIO $4,661.91
- P/E Ratio
- SPHL N/A
- CDIO N/A
- Revenue Growth
- SPHL N/A
- CDIO N/A
- 52 Week Low
- SPHL $0.35
- CDIO $3.22
- 52 Week High
- SPHL $7.80
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- SPHL 42.26
- CDIO 48.60
- Support Level
- SPHL $0.39
- CDIO $3.46
- Resistance Level
- SPHL $0.56
- CDIO $3.77
- Average True Range (ATR)
- SPHL 0.06
- CDIO 0.27
- MACD
- SPHL -0.00
- CDIO 0.03
- Stochastic Oscillator
- SPHL 31.27
- CDIO 67.50
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.